Smoking Cessation
Conditions
Brief summary
COPD is a very common disease, an estimated 3 million people are affected in France. Unfortunately, this pathology is under-diagnosed. Several reasons can be mentioned: the banality of the symptoms or the several comorbidities. Screening faces a major difficulty: the realization of a spirometry. Various studies have shown the complexity of the implementation of mass screening in cities by mini-spirometry. The COPD World Health Days allow this mass screening but without visibility on the actual entry into a care pathway. The objective of this study is to assess the impact of systematic screening for COPD during a tabacology consultation
Interventions
None listed
Sponsors
University Hospital, Brest
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
45 Years to No maximum
Inclusion criteria
* Subjects over 45 years old, followed in Tabacology unit at CHRU of BREST - No COPD patient or COPD patients not followed for more than 3 years (considered out of care) * No opposition filed
Exclusion criteria
* Patients already followed for COPD * Contraindication to spirometry * Refusal to participate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| COPD DIAGNOSIS | day 1 | The diagnosis of COPD is performed using a spirometry |
Countries
France
Outcome results
None listed